Stock-based Compensation (Tables)

3 Months Ended

Mar. 31, 2022

Share-based Payment Arrangement [Abstract]

Schedule of Stock Option Activity

A summary of the Company’s stock option activity for the nine months ended March 31, 2022 was as follows:

	Number of Common Stock Options	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value (In Thousands)
Outstanding as of December 31, 2021	11,507,643	$	1.72
Exercised	(654,935)	1.67
Cancelled/Forfeited	(665,511)	1.67
Outstanding as of March 31, 2022	10,187,197	1.73		7.50	$	143,555

Schedule of Restricted Stock Awards Activity

Restricted stock awards activity for the three months ended March 31, 2022 was as follows:

	Shares	Weighted Average Grant Date Fair Value per Share
Outstanding as of December 31, 2021	666,298	$	1.21
Forfeited	(11,783)	1.22
Vested	(168,144)	1.16
Outstanding as of March 31, 2022	486,371	1.23

A summary of the Company’s restricted stock units activity for the three months ended March 31, 2022 was as follows:

	Shares	Weighted Average Grant Date Fair Value per Share
Outstanding as of December 31, 2021	11,983,032	$	19.56
Granted	4,429,640	14.10
Forfeited	(326,912)	17.94
Vested	(1,494,932)	19.48
Outstanding as of March 31, 2022	14,590,828	17.92

Schedule of Stock-based Compensation Expense by Function

Stock-based compensation expense by function was as follows (in thousands):

	Three Months Ended March 31,
	2022		2021
Cost of sales	$	1,786	$	83
Research and development	7,102		762
Sales and marketing	2,868		186
General and administrative	14,942		806
Total	$	26,698	$	1,837

Stock-based compensation expense by type of award was as follows (in thousands):

	Three Months Ended March 31,
	2022		2021
Equity Classified Awards:
Stock options	$	522	$	163
RSAs	(166)		1,674
RSUs	21,509		—
Liability Classified Awards:
Fixed value equity awards	1,780		—
Optogration awards	3,053		—
Total	$	26,698	$	1,837